Reply

Ann Neurol. 2016 Jan;79(1):161-3. doi: 10.1002/ana.24526. Epub 2015 Dec 12.

Authors

Gemma Tell-Martí^{1

2}, Joan Anton Puig-Butille^{2

3}, Miriam Potrony¹, Celia Badenas^{2

3}, Montserrat Milà^{2

3}, Josep Malvehy^{1

2}, María José Martí⁴, Mario Ezquerra⁴, Rubén Fernández-Santiago⁴, Susana Puig^{1

2

5}

Affiliations

¹ Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute.
² Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute.
³ Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute.
⁴ Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases.
⁵ Medicine Department, University of Barcelona, Barcelona, Spain.

PMID: 26389780
DOI: 10.1002/ana.24526

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Genetic Predisposition to Disease / genetics*
Genetic Variation / genetics*
Humans
Male
Melanoma / genetics*
Parkinson Disease / genetics*
Receptor, Melanocortin, Type 1 / genetics*

Substances

Receptor, Melanocortin, Type 1